A study recently published in Pain Practice found that Platelet-Rich Plasma (PRP) is a more effective therapy against chronic low back pain than a common anti-inflammatory steroid.
Varun Singla, MD and colleagues from the Sanjay Gandhi Postgraduate Institute of Medical Sciences injected 20 patients with PRP (Group P) and 20 patients with methylprednisolone and lidocaine (Group S) into the sacroiliac joint (SIJ). After three months, the efficiency of the steroid injection was reduced to 25%, while the PRP was reduced to only 90%.
Post-injection, patients were asked to fill out the Modified Oswetry Disability Questionnaire and the Short Form Health Survey at two weeks, four weeks, six weeks, and three months. The scores from Group S improved during the first four weeks but then deteriorated up to the three month mark surveyed. In contrast, the scores from Group P showed general improvement during the entire three month period. The authors at Pain Practice recognized PRP injections as “an effective treatment modality in low back pain involving SIJ.”
Dr. Yeomans, a chiropractor in Wisconsin, labeled anesthetic injections to combat SIJ dysfunction pain—similar to Group S—as the gold standard treatment. This study discovering that PRP injections are reasonably more effective could change this gold standard for the better.